Steve Y. Cho, MD
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Chair, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Adjunct Faculty, Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Education & Training
Degree-Granting Education
| 1995 | New York University School of Medicine, New York, New York, US, Doctor of Medicine (M.D.) |
| 1991 | Johns Hopkins University, Baltimore, Maryland, US, Bachelor of Arts (B.A.) |
Postgraduate Training
| 2006-2007 | PET/CT Clinical Fellowship, Johns Hopkins Hospital, Baltimore, Maryland |
| 2004-2006 | Nuclear Medicine Residency, Johns Hopkins Hospital, Baltimore, Maryland |
| 2001-2004 | Clinical Pharmacology Research Training Program (ClinPRAT), National Institutes of Health, Bethesda, Maryland |
| 1998-2001 | Pediatric Hematology/Oncology Clinical Fellowship, Johns Hopkins Hospital, Baltimore, Maryland |
| 1995-1998 | Pediatrics Internship and Residency, Johns Hopkins Hospital, Baltimore, Maryland |
Licenses & Certifications
| 2025 | TX Medical License |
| 2014 | WI Medical License |
Experience & Service
Faculty Academic Appointments
Professor, Department of Radiology, Nuclear Medicine and Molecular Imaging, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2021 - 2025
Associate Professor, Department of Radiology, Nuclear Medicine and Molecular Imaging, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2014 - 2021
Assistant Professor, Johns Hopkins University School of Medicine, Baltimore, Maryland, 2009 - 2014
Assistant Professor, Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 2007 - 2014
Administrative Appointments/Responsibilities
Director, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2022 - 2025
Section Chief, Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2021 - 2025
Associate Section Chief, Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2019 - 2021
ACGME Program Director, University of Wisconsin Hospitals and Clinics, Madison, Wisconsin, 2019 - 2025
Associate Program Director, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2017 - 2019
Director, Department of Radiology, UWSMPH, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin, 2016 - 2025
Director, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2016 - 2025
Associate Director, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2014 - 2025
Co-Director, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 2014 - 2016
Professional Memberships
Grant & Contract Support
| Date: | 2023 - 2027 |
| Title: | Multimodal Learning for Contextually-Aware Longitudinal PET/CT image analysis |
| Funding Source: | N/A |
| Role: | Co-I |
| ID: | 1R01EB033782-01A1 |
Selected Publications
Peer-Reviewed Articles
- Steimle AK, Cho SY, Menon N, Jeraj R, Birbrair A, Albertini MR, Ma VT. ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab. J Immunother 48(8):325-328, 2025. e-Pub 2025. PMID: 40631532.
- Belsky JA, Renfro LA, Keller FG, Hodgson DC, Punnett A, McCarten K, Cho SY, Wu Y, Kelly KM, Castellino SM, Schwartz CL. Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High-Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331. Pediatr Blood Cancer 72(9):e31856, 2025. e-Pub 2025. PMID: 40515508.
- Floberg JM, Kyriakopoulos CE, Cho SY. Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment Response. Adv Radiat Oncol 10(8):101805, 2025. e-Pub 2025. PMID: 40697966.
- Tie X, Shin M, Lee C, Perlman SB, Huemann Z, Weisman AJ, Castellino SM, Kelly KM, McCarten KM, Alazraki AL, Hu J, Cho SY, Bradshaw TJ. Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network. Radiol Artif Intell 7(3):e240229, 2025. e-Pub 2025. PMID: 39969278.
- Santoro-Fernandes V, Schott B, Weisman AJ, Lokre O, Cho SY, Perlman SB, Perk TG, Jeraj R. Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy. J Nucl Med 66(4):565-571, 2025. e-Pub 2025. PMID: 39947917.
- Bruce JY, Burr A, Kimple RJ, Adam DP, Yu M, Piaskowski SM, Glazer TA, Hill P, Hartig GK, McCulloch TM, Wieland AM, Trask D, Oliver K, Longcor J, Rogus-Pulia N, Cho SY, Bednarz B, Harari PM. Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study. EBioMedicine 111:105496, 2025. e-Pub 2025. PMID: 39671752.
- Stoevesandt D, Steglich J, Bartelt JM, Kurch L, McCarten KM, Flerlage JE, Georgi TW, Mauz-Korholz C, Cho SY, Korholz D, Kluge R, Kelly KM, Pelz T, Vordermark D, Hoppe BS, Dieckmann K, Voss SD. CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL). Radiology 314(1):e232650, 2025. e-Pub 2025. PMID: 39835977.
- Tie X, Shin M, Lee C, Perlman SB, Huemann Z, Weisman AJ, Castellino SM, Kelly KM, McCarten KM, Alazraki AL, Hu J, Cho SY, Bradshaw TJ. Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network. ArXiv, 2024. e-Pub 2024. PMID: 38659641.
- Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho SY, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang L. Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 22(6):413-433, 2024. e-Pub 2024. PMID: 39151455.
- Adam DP, Grudzinski JJ, Marsh IR, Hill PM, Cho SY, Bradshaw TJ, Longcor J, Burr A, Bruce JY, Harari PM, Bednarz BP. Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer. Int J Radiat Oncol Biol Phys 119(4):1275-1284, 2024. e-Pub 2024. PMID: 38367914.
- Yousefirizi F, Klyuzhin IS, O JH, Harsini S, Tie X, Shiri I, Shin M, Lee C, Cho SY, Bradshaw TJ, Zaidi H, Benard F, Sehn LH, Savage KJ, Steidl C, Uribe CF, Rahmim A. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis. Eur J Nucl Med Mol Imaging 51(7):1937-1954, 2024. e-Pub 2024. PMID: 38326655.
- Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho SY, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood 143(20):2053-2058, 2024. e-Pub 2024. PMID: 38457359.
- Tie X, Shin M, Pirasteh A, Ibrahim N, Huemann Z, Castellino SM, Kelly KM, Garrett J, Hu J, Cho SY, Bradshaw TJ. Personalized Impression Generation for PET Reports Using Large Language Models. J Imaging Inform Med 37(2):471-488, 2024. e-Pub 2024. PMID: 38308070.
- Sadowski EA, Lees B, McMillian AB, Kusmirek JE, Cho SY, Barroilhet LM. Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer. Abdom Radiol (NY) 48(12):3643-3652, 2023. e-Pub 2023. PMID: 37261441.
- Huemann Z, Lee C, Hu J, Cho SY, Bradshaw TJ. Domain-adapted Large Language Models for Classifying Nuclear Medicine Reports. Radiol Artif Intell 5(6):e220281, 2023. e-Pub 2023. PMID: 38074793.
- Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer 70 Suppl 6(Suppl 6):e30580, 2023. e-Pub 2023. PMID: 37505794.
- Floberg JM, Wells SA, Ojala D, Bayliss RA, Hill PM, Morris BA, Morris ZS, Ritter M, Cho SY. Using (18)F-DCFPyL Prostate-Specific Membrane Antigen-Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy. Adv Radiat Oncol 8(5):101241, 2023. e-Pub 2023. PMID: 37250282.
- Hoppe BS, McCarten KM, Pei Q, Kessel S, Alazraki A, Mhlanga JC, Lai HA, Eutsler E, Hodgson DC, Roberts KB, Charpentier AM, Keller FG, Voss SD, Wu Y, Cho SY, Kelly KM, Castellino SM. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. Int J Radiat Oncol Biol Phys 116(5):1025-1030, 2023. e-Pub 2023. PMID: 36868525.
- Lo AC, Lee I, Pei Q, Wu Y, McCarten KM, Hoppe BS, Hodgson DC, Roberts K, Milgrom S, Kessel S, Cole PD, Kelly KM, Cho SY. Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831. Pediatr Blood Cancer 70(8):e30452, 2023. e-Pub 2023. PMID: 37243975.
- Mhlanga J, Alazraki A, Cho SY, Lai H, Nadel H, Pandit-Taskar N, Qi J, Rajderkar D, Voss S, Watal P, McCarten K. Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer 70 Suppl 4(Suppl 4):e29968, 2023. e-Pub 2023. PMID: 36114654.
- Milgrom SA, Kim J, Pei Q, Lee I, Hoppe BS, Wu Y, Hodgson D, Kessel S, McCarten KM, Roberts K, Lo AC, Cole PD, Kelly KM, Cho SY. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study. Br J Haematol 201(6):1192-1199, 2023. e-Pub 2023. PMID: 36922022.
- Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Schoder H, Wan S, Wester HJ, Hope TA, Herrmann K. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging 50(5):1466-1486, 2023. e-Pub 2023. PMID: 36604326.
- Lawrence EM, Kieler M, Cooley G, Wells SA, Cho SY. Assessment of 18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters for reference standard organs: Inter-reader, inter-modality, and inter-patient variability. PLoS One 18(4):e0283830, 2023. e-Pub 2023. PMID: 37023049.
- Castellino SM, Pei Q, Parsons SK, Hodgson D, McCarten K, Horton T, Cho S, Wu Y, Punnett A, Dave H, Henderson TO, Hoppe BS, Charpentier AM, Keller FG, Kelly KM. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. N Engl J Med 387(18):1649-1660, 2022. e-Pub 2022. PMID: 36322844.
- Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS. Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. Blood 140(10):1086-1093, 2022. e-Pub 2022. PMID: 35763667.
- Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA. Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. J Clin Oncol 40(19):2106-2118, 2022. e-Pub 2022. PMID: 35271306.
- Grudzinski JJ, Hall LT, Cho S, Liu G, Traynor A, Lee MH, Longino M, Pinchuk A, Jaskowiak C, Bednarz B, Weichert J, Kuo JS. Clinical Imaging and Dosimetry of a Pan- Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404. Radiation 2(2):215–227, 2022. e-Pub 2022.
- Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 112(4):890-900, 2022. e-Pub 2022. PMID: 34767937.
- Zukotynski KA, Emmenegger U, Hotte S, Kapoor A, Fu W, Blackford AL, Valliant J, Benard F, Kim CK, Markowski MC, Eisenberger MA, Antonarakis ES, Pienta KJ, Gorin MA, Lubanovic M, Kim J, Pomper MG, Cho SY, Rowe SP. Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted (18)F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide. J Nucl Med 62(10):1430-1437, 2021. e-Pub 2021. PMID: 33608426.
- Ng TSC, An BP, Cho SY, Hyun H. US Trainee and Faculty Perspectives on Exposure to Nuclear Medicine/Molecular Imaging During Medical School. Curr Probl Diagn Radiol 50(5):585-591, 2021. e-Pub 2021. PMID: 32653243.
Review Articles
- Oh C, Bishop MW, Cho SY, Im HJ, Shulkin BL. (18)F-FDG PET/CT in the Management of Osteosarcoma. J Nucl Med 64(6):842-851, 2023. e-Pub 2023. PMID: 37201958.
- Fowler AM, Cho SY. PET Imaging for Breast Cancer. Radiol Clin North Am 59(5):725-735, 2021. e-Pub 2021. PMID: 34392915.
Letters to the Editor
- Torres-Velazquez M, Parker M, Bo A, White M, Tanabe S, Pearce RA, Lennertz R, Cho SY, Bendlin B, Johnson SC, Prabhakaran V, McMillan AB, Sanders RD. Amyloid deposition on positron emission tomography correlates with severity of perioperative delirium: a case-control pilot study. Br J Anaesth 128: e226-e228, 2022.
Patient Reviews
CV information above last modified February 05, 2026